on Biophytis (EPA:ALBPS)
Results of Biophytis' General Meeting Held on November 13, 2025
Biophytis SA has announced that all resolutions proposed at the Combined General Meeting on November 13, 2025, have been approved. This significant event was supported by a 31% quorum of shareholder participation. The resolutions involved included the approval of the financial statements for the fiscal year 2024.
Biophytis continues to innovate in the field of transformative therapies. The approval at this meeting marks a step towards further advancements. Shareholders can review the detailed voting results on the company's website in the "General Meetings" section.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Biophytis news